SCHEMBL1870286

SCHEMBL1870286

CC(c1ccccc1)c1cncc(C(=O)N2CCN(c3cccc(C#N)c3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HRH3 Q9Y5N1 1/20 0.45
SMO Q99835 1/20 0.45
TSHR P16473 2/20 0.45
USP2 O75604 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
NAMPT P43490 1/20 0.44
SLC6A7 Q99884 1/20 0.43
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
MGLL Q99685 1/20 0.42
KHK P50053 1/20 0.41
NOTUM Q6P988 1/20 0.41
DRD2 P14416 1/20 0.41
PHGDH O43175 1/20 0.41
CHRM4 P08173 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498937 0.83 FASN (0.46) HRH3MGLLDRD2
SCHEMBL1873912 0.83 ALDH1A1 (0.49) ALDH1A1TSHRUSP2LMNAMAPT
Hydrochloric Acid SCHEMBL1866745 0.82 ALDH1A1 (0.48) ALDH1A1TSHRUSP2LMNAMAPT
Hydrochloric Acid SCHEMBL1872132 0.82 ALDH1A1 (0.48) ALDH1A1TSHRUSP2LMNAMAPT
SCHEMBL1870287 0.80 CHRM4 (0.48) ALDH1A1SMOTSHRUSP2LMNA
SCHEMBL6493544 0.74 FNTA (0.58) SMOTSHRUSP2LMNAMAPT
SCHEMBL21169266 0.73 DRD2 (0.55) ALDH1A1TSHRLMNAMAPTMAPK1
SCHEMBL5763718 0.72 DRD2 (0.60) TSHRUSP2LMNAMAPTMAPK1
SCHEMBL27405039 0.72 MAOB (0.60) ALDH1A1USP2LMNAMAPTNAMPT
SCHEMBL30961626 0.72 MGLL (0.54) ALDH1A1HRH3USP2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947684-B2 anticoagulants; immunomoderators; antiinflammatory agents AVENTIS PHARMACEUTICALS INC. (US) 2011-05-24 US disclosed
US-20040220171-A1 1-Aroyl-piperidinyl benzamidines AVENTIS PHARMACEUTICALS INC 2004-11-04 US disclosed
US-20020045613-A1 1-aroyl-piperidinyl benzamidines AVENTIS PHARMACEUTICALS PRODUCTS INC. 2002-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040220171-A1 1-Aroyl-piperidinyl benzamidines TPSAB1, TPSB2, CMA1 ALDH1A1 567/4885HRH3 126/4885SMO 3301/4885
US-20020045613-A1 1-aroyl-piperidinyl benzamidines TPSAB1, TPSB2, CMA1 ALDH1A1 567/4885HRH3 126/4885SMO 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.